Unleashing the Power of AI in Genomics Market: Revolutionizing Healthcare with Cutting-Edge Artificial Intelligence Solutions

The ai in genomics market size has grown exponentially in recent years. It will grow from $0.75 billion in 2023 to $1.08 billion in 2024 at a compound annual growth rate (CAGR) of 43.9%. The growth in the historic period can be attributed to advancements in genomic sequencing, data handling challenges, personalized medicine demand, disease understanding and diagnosis, drug discovery and development..

The ai in genomics market size is expected to see exponential growth in the next few years. It will grow to $4.58 billion in 2028 at a compound annual growth rate (CAGR) of 43.4%. The growth in the forecast period can be attributed to expansion of genomic databases, enhanced genomic data security, ai-driven biomarker discovery, integration with other 'omics' data, patient empowerment and education.. Major trends in the forecast period include ai in cancer genomics, ai-enhanced genomic imaging, ai-driven biomarker discovery, genomic data integration across healthcare systems, ai in functional genomics research..

Market Overview -
AI in genomics is a set of computer tools used by genomics researchers to manage and understand any important information concealed in big datasets for DNA sequencing and other biological procedures. These algorithms are capable of detecting human genetic patterns and abnormalities in genomic data.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=9612&type=smp

Growing Adoption Of Ai Drives The Ai In Genomics Market
Growing adoption of AI is expected to propel the growth of the AI in genomics market going forward. Artificial intelligence (AI) is a field that uses computer science and large datasets to solve problems. It includes the subfields of machine learning and deep learning, commonly referenced in the context of artificial intelligence. AI in genomics assists in identifying genetic illnesses and the primary type of cancer, forecasting the progression of certain diseases in a patient, identifying disease-causing genomic variations, and improving the function of gene editing tools. Additionally, due to such benefits, there is an increased demand for artificial intelligence (AI) in genomics. For instance, in May 2022, according to a report published by International Business Machines Corporation (IBM), a US-based technology corporation, The global adoption rate of AI climbed dramatically to 35%, up four percent from the previous year. Additionally, a survey of 7,502 company decision-makers shows that 13% more enterprises are expected to utilize AI in 2021 than in 2020. 35% of organizations reported employing AI, 42% are contemplating AI adoption, and two-thirds (66%) are either executing or aiming to use AI to fulfil their sustainability goals. Therefore, the growing adoption of AI is driving the growth of the AI in genomics market.

Competitive Landscape -
Major companies operating in the ai in genomics market report are International Business Machines Corporation, Microsoft Corp., NVIDIA Corporation, Deep Genomics Inc., BenevolentAI Ltd., Fabric Genomics Inc., Verge Genomic Inc., Freenome Holdings Inc., MolecularMatch Inc., SOPHiA GENETICS SA, Data4Cure Inc., PrecisionLife Ltd., Genoox Ltd., Lifebit Ltd., Empiric Logic Ltd., FDNA Inc., DNAnexus Inc., Engine Biosciences Pte Ltd., 4baseCare, Congenica Ltd., CytoReason Ltd., Emedgene Technologies LTD, Illumina Inc., Lifebit Biotech Ltd., Mendel.ai, Predictive Oncology Inc., Tempus Labs Inc., 10x Genomics Inc., Repositive Limited, Genedata AG, Global Gene Corp, Nference Inc., Bluebee Holding B.V., Genomenon Inc. .

Ai-Driven Solution Revolutionizing High-Resolution Analysis In The AI In Genomics Market
Technological advancements are a key trend gaining popularity in the AI in genomics market. Major companies operating in the AI in genomics market are focused on developing innovative technological solutions to strengthen their position in the market. For instance, in March 2023, Genomic Vision, a France-based biotechnology company that specializes in the development of diagnostic solutions for genetic diseases and cancers, launched FiberSmart, an AI-powered software that enables the visualization and analysis of long DNA fibers at high resolution. has the potential to completely change the diagnosis and treatment of genetic illnesses. It was introduced to increase the precision and effectiveness of diagnosing and treating genetic diseases. Large amounts of data are analyzed using this technology to find patterns and insights that would be impossible for humans to find on their own.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/ai-in-genomics-global-market-report

Key Segments -

The ai in genomics market covered in this report is segmented -

1) By Component: Hardware, Software, Services
2) By Technology: Machine Learning, Computer Vision
3) By Functionality: Genome Sequencing, Gene Editing, Other Functionalities
4) By Application: Drug Discovery And Development, Precision Medicine, Diagnostics, Other Applications
5) By End-use: Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.